Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
about
Imaging radiation response in tumor and normal tissue.¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy(18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.The role of PET in monitoring therapy.Predicting Response to Neoadjuvant Chemotherapy with PET Imaging Using Convolutional Neural Networks.Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapyPositron emission tomography imaging approaches for external beam radiation therapies: current status and future developmentsMonitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.Application of FDG-PET/CT in Radiation Oncology.Temporal analysis of intratumoral metabolic heterogeneity characterized by textural features in cervical cancer.Elevation in exhaled nitric oxide predicts for radiation pneumonitis[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.The prognostic value of PET and PET/CT in cervical cancerRadiation pneumonitis: correlation of toxicity with pulmonary metabolic radiation responseImaging radiation-induced normal tissue injuryFluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapyPosttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy.PET/CT in radiation oncology.Application of metabolic PET imaging in radiation oncology.Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography.Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning.A new method to assess pulmonary changes using (18)F-fluoro-2-deoxyglucose positron emission tomography for lung cancer patients following radiotherapy.Prognositc significance of SUVmax on pretreatment 18 F-FDG PET/CT in early-stage non-small cell lung cancer treated with stereotactic body radiotherapy: A meta-analysis.PET tracer development--a tale of mice and men.Exploring feature-based approaches in PET images for predicting cancer treatment outcomes.Positron emission tomography in the management of lung cancer.Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation.The value of nodal information in predicting lung cancer relapse using 4DPET/4DCT.Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.Quantitative analysis of pre- and post-treatment PET-CT scans using deformable image registration methods.Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer.Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.Positron-emission tomography CT to identify local recurrence in stage I lung cancer patients 1 year after stereotactic body radiation therapy.A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer.
P2860
Q26798266-86696715-01D4-4B77-9798-7A5DABEF096DQ30980315-6E4E75A5-3083-4496-89BD-D9F77B1F2055Q33664774-9EE2AFE9-50A3-4A25-BAF9-2DC621F6A01BQ33973399-DF52BA47-9F9C-42E2-9413-5FDC237CD9AAQ34978457-57C690E8-101F-4F65-B6DA-BD6853546857Q35172974-83EA8A1D-88F5-4BF3-8092-72AEA3EADFB0Q35768828-FAD873FA-7C76-4D41-B883-9AAD4083F7C1Q35843758-3795BEF4-BA61-42D9-A136-92C65BDE0EE6Q36239986-697B1DDB-32C6-4C94-911E-3AF53FB4BDFFQ36325435-EC88646A-E5D5-4874-99E7-B2573201D26CQ36393691-11486E02-399A-4EEA-916B-4C1C24AD29CBQ36756445-1260609D-7423-4E53-A626-D00403A4C36EQ36763115-F5960190-36F0-4B9C-B1D4-8A6269BDFF95Q36766529-07043688-8F15-4493-A553-FFF9E6748F73Q36766549-EA24D516-5566-4355-B80C-FEFF5569BA30Q36836254-4E5BB20B-232B-4212-AD3B-CB47F594C909Q36968113-E69AD3DC-7484-4D21-8601-8922290E806AQ37070104-041AC67F-10AA-493A-8EBA-96C27E5F8EDEQ37231172-D236C224-5EE9-4945-BD0F-817C229B3079Q37235767-5453A1CF-BB9C-4AB9-8B6E-3DE7E4461BFFQ37345402-DF0E973B-E9BD-437B-8DAD-7EEC38395627Q37580845-70BDD0D8-3D03-4DE0-BECF-FBCCAC508E41Q37643555-E47C6C1F-DBCC-46FA-AFA4-AD5AD1EC5FBDQ37817035-1DED56C6-601F-43C5-B9E6-3786F6EA0420Q38232757-B9DA5A26-0782-42C8-9292-99F563D989CBQ38636302-5564B68C-85C5-439E-BAC8-B4817F651C9DQ38925620-D9E0D1F4-F0D8-4DAB-B1EB-11600122DB0AQ40268582-8DF4A09A-59E3-4B63-9985-3D5AB4C540E8Q41790286-689400D9-8719-4F4C-81CF-693E2A067C47Q42056666-CE5AC04C-07D7-45D4-B066-7874F1B266B6Q42232269-06A099BA-EB14-4EF0-8978-292F94A82C52Q43089571-808FA45F-6DE4-4A16-AB7B-1A02773ABFCBQ45953810-7850B16E-8FA4-4C54-9412-251E52957973Q47138202-422C17DD-D635-455A-B49E-B4280040BC5FQ47141669-E7C835D4-0A6F-416B-8AA3-7074DD702B30Q51644443-D62BD847-F9A2-4646-A0D9-0920A2A96AC4Q52624089-EA9FD3E3-5A20-4D86-B6EE-D5F387AA7B2AQ53088229-3E8E9DDD-8E52-47E9-9C50-E63B6B841387Q53112046-4B1FDB00-884A-4A98-8851-14C4850AB10AQ55279852-40FF04D3-CB23-4B28-B740-42EF4DE7D918
P2860
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@en
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@nl
type
label
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@en
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@nl
prefLabel
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@en
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@nl
P2093
P1476
Early FDG-PET imaging after ra ...... erapeutic response evaluation.
@en
P2093
Annette Hogg
Danny Rischin
David L Ball
Jane P Matthews
Lester J Peters
Michael P Mac Manus
P304
P356
10.1016/J.IJROBP.2004.03.036
P407
P577
2004-10-01T00:00:00Z